Cochlear Limited (ASX:COH) is a health care equipment and services company which was listed on the Australian Securities Exchange (ASX) on 4 December 1995 under the ticker code COH. The company is headquartered in New South Wales and claims to be a global leader in implantable hearing solutions. As per the company’s website, Cochlear invests over AU$180 million each year in research and development and has a global workforce of over 4,000 people. In terms of innovation, the company has been working with Apple for over ten years to create the first made for iPhone implantable hearing solutions. The company has also collaborated with ReSound, known as a pioneer in the hearing aid industry, to provide hearing solutions to all sorts of hearing loss. Products and accessories offered by Cochlear are designed for both children and adults. Cochlear technology offers multiple ways to hear, ranging from automatically adjusting hearing to various environments to hearing sounds from a smartphone. The products offered by the group are Cochlear Nucleus System and Cochlear Osia System. The accessories assist the user in watching movies, chatting on phones, go for swimming and listening to music. The accessories are True Wireless Devices and Nucleus water safe accessories.
Corporate Information
1 University Avenue, MACQUARIE UNIVERSITY, NSW, AUSTRALIA, 2109